Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.
<h4>Objective</h4> <p>To compare myelin and astrocyte injury in patients with antibodies against myelin oligodendrocyte glycoprotein (anti-MOG) or aquaporin-4 (anti-AQP4), and multiple sclerosis (MS).</p> <h4>Methods</h4> <p>Myelin basic protein (MBP) and gl...
Auteurs principaux: | Kaneko, K, Sato, D, Nakashima, I, Nishiyama, S, Tanaka, S, Marignier, R, Hyun, J, Oliveira, L, Reindl, M, Seifert-Held, T, Sepulveda, M, Siritho, S, Waters, P, Kurosawa, K, Akaishi, T, Kuroda, H, Misu, T, Prayoonwiwat, N, Berger, T, Saiz, A, Kim, H, Nomura, K, Callegaro, D, Fujihara, K, Aoki, M |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
BMJ Publishing Group
2016
|
Documents similaires
-
Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
par: Sato, D, et autres
Publié: (2014) -
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
par: Waters, P, et autres
Publié: (2015) -
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
par: Sato, D, et autres
Publié: (2014) -
Prevalence and clinical characteristics of neuromyelitis optica spectrum disorders patients with myelin oligodendrocyte glycoprotein antibodies
par: Sato, D, et autres
Publié: (2013) -
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
par: Jarius, S, et autres
Publié: (2018)